Form D · Biotechnology

Circulate Health, Inc.

Seattle, WA · CIK 0002078196

Offering snapshot reported Jan 9, 2026 · SEC filing

Reported sold
$13M
Offering amount: $13M
Investors reported
4
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jun 11, 2025
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$6.5M$13MOct 22, 2025: $10,600,001.00Oct 22, 2025Jan 9, 2026: $13,000,000.00Jan 9, 2026

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$10,600,001 → $13,000,000
  • Reported investors3 → 4

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jan 9, 2026Amendment$13,000,000$2,399,999vs Oct 22, 20254SEC filing
Oct 22, 2025Initial$10,600,001No comparison3SEC filing

Offering details

Securities
Equity, Option to acquire, Security to be acquired
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-561676

Source: Form D, filed Jan 9, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Uri Greenwald Director
Robbie Schwietzer Executive
Brad Younggren Director, Executive, Promoter

Issuer details

Industry: Biotechnology (See others in industry)

Address:
1424 11 Th Ave Ste 400
Seattle, WA, 98122